IndieBio: How can the US be globally competitive in bio-manufacturing

While the U.S. leads in bio-innovation, translating breakthrough science into scalable manufacturing remains our biggest competitive gap. From nutritional proteins to new materials to cell therapies, mastering bio-manufacturing at scale will dominate the next trillion-dollar economy—but winning doesn't mean going it alone.

This conversation explores how strategic international partnerships can accelerate American bio-manufacturing leadership without compromising competitive advantage. Expect practical insights on when to compete, when to collaborate, and how to leverage America's unique strengths in an interconnected bio-economy.

Panelists:

Maximilian Von Poelnitz: Managing Director, Ajinomoto CVC

Doug Friedman: CEO, BioMADE

Po Bronson: Managing Director of IndieBio, GP at SOSV